- Bastian, Boris;
- Leboit, Philip;
- Yeh, Iwei;
- Botton, T;
- Talevich, E;
- Shain, AH;
- Sparatta, AJ;
- De, A;
- Mully, TW;
- North, JP;
- Garrido, MC;
- Gagnon, A
Oncogenic gene fusions have been identified in many cancers and many serve as biomarkers or targets for therapy. Here we identify six different melanocytic tumours with genomic rearrangements of MET fusing the kinase domain of MET in-frame to six different